Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. Medications for high blood pressure include: Diuretics; Beta-blockers; ACE inhibitors; Angiotensin-receptor blockers; Calcium channel blockers; Alpha-blockers. The impurity detected in the finished drug product is N-nitrosodiethylamine, which is has been classified as a probable human carcinogen. Top Searches Holiday Gifts. Kirk Hessels, a spokesman for Camber, didn't immediately respond to requests for comment on Friday. FOLLOW ANNALISE KNUDSON ON FACEBOOK AND TWITTER . The recall suggests that patients who use these medications should contact their pharmacist or physician for advice on alternative treatment before returning their medication. Mylan Pharmaceuticals Inc./Mylan Laboratories Limited. Those suppliers provide components including inactive ingredients, of which Diovan has about eight. —The 104 additional lots include 26 lots of Amlodipine and Valsartan tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg strengths). » RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say. Approval was granted to India-based Alkem Laboratories Limited. For every 8,000 people who took the highest dose of valsartan contaminated with NDMA, there would be one additional case of cancer, the FDA has estimated. “But most people probably would not do that.”, The FDA has said in its information for consumers, “Our scientists estimate that if 8,000 people took the highest daily valsartan dose (320 mg) that contained NDMA, for four years (the amount of time we believed the affected products had been on the U.S. market), there may be one additional case of cancer beyond the average cancer rate among Americans.”. Some of the batches aren’t due to expire until August 2020. Subscribe to MassLive.com. It is rarely used due to its numerous side effects and drug interactions. Teva Pharmaceuticals has issued a voluntary recall … According to the Food and Drug Administration, NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes. Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens. The three impurities are chemical compounds in the nitrosamines class and NDEA and NDMA are considered to be a probable cancer-causing risk in humans at certain exposure levels, and NDMA a potential one. “Trace amounts normally wouldn’t worry me, but trace amounts - along with other exposures - build up and that is my concern with carcinogens and taking something tainted everyday,” the consumer said. The FDA posted Mylan labels, also at fda.gov. The official had recommended Zhejiang Huahai, one of China's largest exporters of pharmaceuticals, receive a warning from the agency, but was overruled by higher-ups at the FDA. Valsartan has been in shortage since August, and the agency warned in its statement that "other types of products may fall into shortage soon," without offering any specifics. For a complete list of the recalled medication, click here. The FDA also posted labels of the Teva lots affected. The latest news is that Torrent Pharmaceuticals Limited is further expanding its recall of Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, … . In standalone and combined forms, valsartan has been a go-to therapy for cardiovascular issues for a generation. Camber said in a statement on Thursday that it was recalling 87 lots of losartan tablets due to the discovery. The drugs under voluntary recall block receptors in the body that contribute to conditions like high blood pressure. To date, Camber has not received any reports of adverse events related to this recall. NMBA is a potential human carcinogen. You may have questions, we have answers. DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen. —Also: 51 lots of Valsartan tablets, USP (including 40 mg, 80 mg, 160 mg and 320 mg strengths), and 27 lots of Valsartan and Hydrochlorothiazide tablets, USP (80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg and 320mg/25mg strengths). If you take valsartan for your high blood pressure, check the FDA lists. The Food and Drug Administration (FDA) is issuing a worldwide recall for a blood pressure and heart failure medication that contains an active ingredient linked to an impurity that is a known probable human carcinogen. Alembic doesn't use DMF in its manufacturing process, according to spokesman Ajay Desai, who said the contamination likely occurred during analysis. The U.S. Food and Drug Administration is alerting patients and health care professionals to another recall of medications used to treat high blood pressure and heart failure due to the presence of a potential cancer-causing substance. / Blood Pressure Medication Recall List. The recalls were over the presence of NMBA. The focus surrounding valsartan has been on the active ingredient, largely supplied to the companies under recall by Zhejiang Huahai Pharmaceutical Co. in China and Hetero Labs in India. These product labels provided by fda.gov are for the Mylan recalled lots. “Out of an abundance of caution, these products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited,” the Food and Drug Administration posted Tuesday. Torrent Pharmaceuticals Limited recalled two lots of Losartan potassium tablets, USP because of trace amounts of N-nitrosodiethylamine (NDEA), which is a probable human carcinogen. The FDA said in a March 22 posting on its website that it has updated the list of valsartan medicines under recall to incorporate additional repackagers of Aurobindo’s valsartan-containing medicine. Another 35 lots of heart and blood pressure medication losartan have been recalled because of unsafe amounts of NMBA in the active ingredient. FRIDAY, March 8, 2019 -- People taking blood pressure medications have faced a frightening and bewildering series of pharmaceutical recalls in recent months, as trace amounts of cancer-causing chemicals have been discovered in … The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. Twitter Share. Yet another blood pressure medication has been added to the list of recalled hypertension drugs. The FDA announced March 12 that it had prioritized approval of another generic version of Diovan, that is, valsartan, in recognition of the multiple recalls of ARB medicines over the detection of nitrosamine impurities above interim acceptable intake limits. Valisure found DMF in valsartan made by five of the six drugmakers it tested, including Novartis, which makes the brand-name version called Diovan. As blood-pressure drug recall widens, doctors say patients should pay attention, but warned against dropping a medication without professional guidance. An online pharmacy told U.S. regulators it found another cancer-causing chemical in widely prescribed blood-pressure pills, raising new questions about a complex global web of companies that produces medicine for millions of people. For people with high blood pressure, fluctuating readings are a warning sign that you might need to change medication. An expansion of the recall was announced March 19, 2019, on fda.gov: As of March 15, 2019, according to fda.gov: Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. According to fda.gov, as of Feb. 22, 2019: Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical ingredient made by Hetero Labs Limited. The full list of expanded recalled batches can be viewed at https://www.fda.gov/Safety/Recalls/ucm627647.htm. He added that his letter referenced that "some bottles of valsartan were recalled because of purity issues" but did not mention them as carcinogenic. Updated Sep 30, 2019; Posted Sep 30, 2019 . Representatives for Aurobindo and Lupin didn't respond to requests for comment. New research presented today at … A number of medications in the class of drugs known as angiotensin II receptor blockers have been under voluntary recall since July because of the detection of unacceptable levels of N-Nitrosodiethylamine (NDEA) and/or N-nitrosodimethylamine (NDMA) and, more recently, N-Nitroso N-Methyl 4-amino butyric acid (NMBA), in their active pharmaceutical ingredient such as losartan and valsartan as well as irbesartan. Diovan's DMF levels were among the lowest that tested positive. FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure Prinston Pharmaceutical Inc., dba Solco Healthcare LLC. In the 1950s, reserpine was one of the few products on the market to treat hypertension. The U.S. Food and Drug Administration has updated its lists of valsartan and losartan-containing blood pressure medicines under recall due to the … The drugs, angiotensin II receptor blockers (ARBs), work by widening or … Legacy Pharmaceutical Packaging issued two company announcements March 15, saying in one that it was recalling 40 repackaged lots of losartan tablets in 25-milligram, 50-mg, and 100-mg dose due to distributor Camber Pharmaceuticals Feb. 28 voluntary recall, and in another that it had recalled three repackaged lots of losartan tablets in 50-mg dose due to Torrent Pharmaceuticals voluntary nationwide March 1 recall of several lots of losartan tablets. Note to readers: if you purchase something through one of our affiliate links we may earn a commission. Lawyers for plaintiffs, including 34 people and insurers that paid for contaminated drugs, filed a class-action complaint Monday claiming that Zhejiang Huahai's actions constitute "an explicit effort to conceal and destroy evidence and to willfully and recklessly introduce adulterated and/or misbranded" valsartan into the market. Which blood pressure medication that has the lowest side effects depends on how you react to specific medications and what side effects you find most bothersome. On Jan. 18, 2019, Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., initiated a voluntary recall of one (1) lot of Irbesartan and seven (7) lots of Irbesartan HCTZ Tablets used to treat blood pressure. These batches were distributed domestically between March 2017 and November 2018. Updated June 27, 2019, with new recall lots. 4 questions and answers for consumers about FDA’s recent high blood pressure medication recall. A carcinogen is something that could cause you to have cancer. Hundreds of lots of the medication have been recalled since last July. An FDA statement Friday disclosed that the contaminants, called N-Nitrosodimethylamine and N-Nitrosodiethylamine, are created when "specific chemicals and reaction conditions are present . Valsartan Tablets USP 160 mg, 100 count Unit Dose Blisters This recall was prompted due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer). Company Medicine NDC Lot Number Expiration; A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17019: 09/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17018: 08/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) … That drug was first approved in the U.S. in 1996. Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. © 2021 Advance Local Media LLC. A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in … Reminder: Don’t stop your medicine without contacting your healthcare provider .The risk of abrupt discontinuation of BP drugs can be significant. The agency is urging patients to continue taking their medications until a pharmacist or doctor provides another option because they need to balance the risks of out-of-control blood pressure against that of a tiny elevated risk of cancer. To break them down, a solvent like DMF may be used, but it's supposed to largely vanish by the time a pill is put into a bottle for sale. If you take valsartan for your high blood pressure, check the FDA lists. Blood Pressure Medication Recalled FDA says active ingredient is linked to a known probable carcinogen. Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. A recent letter one consumer received from his pharmacy alerting him to check to see if his medication containing valsartan was among the lots listed in the letter under recall for “purity issues.”. (Individual Dose NDC: 60687-139-11). Drugs used to treat High Blood Pressure The following list of medications are in some way related to, or used in the treatment of this condition. According to the assessments that it has posted online, the FDA hasn't yet screened valsartan that Valisure tested from Aurobindo Pharma Ltd., Lupin Ltd. and Novartis. The Food and Drug Administration has recently recalled a number of … More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Zhejiang Huahai has said it has been in close contact with the FDA since the recall began. Twitter Share. Here are the 10 lots. American Health Packaging issued a voluntary recall March 7 of one lot of valsartan tablets in 160-mg dose prompted by manufacturer AurobindoPharma USA’s March 1 voluntary recall of additional lots of valsartan due to the detection of NDEA in the active pharmaceutical ingredient. The FDA allows drugs to contain the equivalent of about 8.8 million nanograms of daily exposure to DMF. The agency said that the risk of a patient who took a recalled ARB getting cancer is low. Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens. April 19, 2019 / 1:31 PM / CBS News The FDA, which has issued acceptable intake levels for these nitrosamines that may result from the manufacturing process, has been working with their manufacturers to update testing and to reduce and remove them. More blood pressure medications added to growing recall list The drugs are manufactured by Teva Pharmaceuticals. By Bloomberg . A Food and Drug Administration recall of a heart medication due to a cancer-causing chemical now includes two blood pressure medications. Valsartan is a decades-old treatment for hypertension that is frequently combined with other medicines into a single pill. The FDA regulates those less stringently than the active ingredients that fight disease. DMF is cheaper than some other solvents, making it appealing for companies coping with the bruising economics of the generic-drug business. Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (each updated 1/1/21). The voluntary recall was expanded in December by Mylan to all unexpired lots. Blood pressure medication recall expanded again over potential cancer-causing ingredient. At the top of this list is the newly recalled lots. The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow. » RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say ** Most commonly prescribed blood pressure medications have an array of similar side effects. In addition, it has updated the list of valsartan medicines not under recall as of March 19. An FDA spokeswoman said the investigation continues and it is impossible to predict how many more recalls there might be. … Teva Pharmaceuticals has issued a voluntary recall of its amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets, both used to treat high blood pressure, according to the FDA. Blood pressure medication recall expanded again over potential cancer-causing ingredient. Keep reading to find information about the earlier Teva recall and voluntary recalls by many other companies that make blood pressure medications. An Attorney who has filed 12 high blood pressure medication lawsuits so far, told judges at a conference in the U.S. District Court in New Jersey last month he expected there to be at least 2000 high blood pressure medication lawsuits filed within the next two years. "This is what made me look up the website given in the letter on the FDA recall," he said. The agency last revised its allowable solvent levels in 2017; the WHO classified DMF as a probable carcinogen in 2018. The agency said those byproducts would not have been detected in routine inspections because the process depends on scientists knowing which chemical intruders are likely to be accidentally created during the process, knowledge that they said regulators and companies lacked until recently. Updated Sep 30, 2019; Posted Sep 30, 2019 . To date, Legacy has not received any reports of adverse events related to this recall. (CBS) Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. The government site also says the risks of going off the medication may be greater than the risk of taking it so patients should not stop but should contact their health care provider or pharmacist for guidance. For now, if you are taking blood pressure medications, or any medications for that matter, pay attention to FDA warnings and recall news. A representative for Macleods couldn't be reached for comment. This includes some combination tablets which contain valsartan and amlodipine or valsartan, amlodipine, and hydrochlorothiazide. FDA has issued a recall of certain lots of angiotensin II receptor blocker (ARB) high blood pressure medication containing valsartan, losartan, or irbesartan. The Food and Drug Administration (FDA) is issuing a worldwide recall for a blood pressure and heart failure medication that contains an active ingredient linked to an impurity that is a known probable human carcinogen. Fda.gov said the recall was due to t to the detection of trace amount of an unexpected impurity. The agency has downplayed the public health risks of the contamination, pointing out that if 8,000 people took the highest dose of one drug, valsartan, for four years, there could be one additional case of cancer. Novartis doesn't use DMF in making Diovan and documents provided by suppliers it purchases ingredients from indicate that they don't, either, said spokesman Althoff. . According to fda.gov: NMBA is a potential human carcinogen. Late last month, Teva Pharmaceuticals pulled all lots of Amlodipine/Valsartan and Amlodipine/Valsartan/Hydrochlorothiazide combination tablets for the same reason: too much NDEA in its Valsartan, the active ingredient made by Mylan India. But the official limit considered "safe" for human consumption brings a much lower risk than the possible exposure from tainted drugs - causing less than one additional case of cancer in 100,000 people over a lifetime. Next 21 results. When American Health Packaging recalled one lot of valsartan pills on March 7, the Public Interest Research Group said it was the 75th recall of blood pressure medications since the … See also: sub-topics. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. Some forms of valsartan may contain a cancer-causing agent, FDA says. blood pressure medication recall list 2019: blood pressure medication recall list 2018: 12 3. The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow. Making Sense of the Recent Blood Pressure Drug Recalls. In November, Mylan also recalled 15 heart attack and blood pressure medications and Sandoz recalled Losartan blood pressure meds. (CBS) Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. A solvent called dimethylformamide was discovered in the drug valsartan made by several companies, including Swiss pharmaceutical giant Novartis, according to a filing last week to the Food and Drug Administration by New Haven, Connecticut-based Valisure. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan making the total for one week to four recalls. The company added five lots of the generic drug losartan (three lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide tablets) to an April recall of more than 100 lots of the same medications. Company Medicine NDC Lot Number Expiration; A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17019: 09/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17018: 08/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) … In July, five medications of Valsartan/Hyrdrochlorothiazide blood pressure drugs manufactured by Major Pharmaceuticals, Teva Pharmaceuticals and Solco Healthcare were recalled. Here's how to know what medications were impacted and who to contact. The FDA maintains a … Community Rules apply to all content you upload or otherwise submit to this site. By Howard Cohen / Miami Herald Sunday Dec 9, 2018 at 8:31 AM. As of March 19, 2019, the Legacy Pharmaceutical Packaging recall was expanded, affecting 40 lots. Some of the valsartan that was positive for DMF was on a list of medicines the FDA had earlier deemed safe to use amid the recalls, including drugs manufactured by Alembic Pharmaceuticals Ltd. and Macleods Pharmaceuticals Ltd., both based in India. You may have recently heard that FDA has recalled several blood pressure medications. A week after two more blood pressure drugs were recalled because they have a possible cancer-causing ingredient, the U.S. based Mylan Pharmaceuticals expanded its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within dates of expiration. The company said it hadn't received any reports of patients being harmed related to the recall. In November, Mylan also recalled 15 heart attack and blood pressure medications and Sandoz recalled Losartan blood pressure meds. Only Generics. An Attorney who has filed 12 high blood pressure medication lawsuits so far, told judges at a conference in the U.S. District Court in New Jersey last month he expected there to be at least 2000 high blood pressure medication lawsuits filed within the next two years. Getty Images. By Bloomberg . Getty Images. The U.S. Food and Drug Administration has updated its lists of valsartan and losartan-containing blood pressure medicines under recall due to the detection of an impurity considered carcinogenic above certain levels in the active pharmaceutical ingredient. 1 Wonder Woman 1984; 2 Susan Moore; 3 Rush Limbaugh; 4 Stephanie Mohr; 5 Emergency Food Supply; 6 Ron Burkle; 7 Private Jets Sale; 8 Dog Pet Insurance; 9 Playboi Carti; 10 Leslie West; Top Searches Holiday Gifts. All rights reserved (About Us). Here are the Teva lots under recall as of November 2018, according to fda.gov. A carcinogen is something that could cause you to have cancer. American Health Packaging added to the list of recalls on March 7, 2019. Anne-Gerard Flynn | Special to The Republican. Following that is earlier Mylan recalls. Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (each updated 1/1/21). See list above for the lots recalled in December. The FDA said March 20 that to “ensure patient access to losartan” that it will “not object to certain manufacturers temporarily distributing losartan” with NMBA above the interim acceptable intake levels “of 0.96 parts per million (ppm) and below 9.82 ppm until the impurity can be eliminated.". (RNN) – A recall traced to the widely-used blood pressure medication valsartan has expanded to two new products, produced by a previously affected drugmaker. Blood Pressure Medication Recalled FDA says active ingredient is linked to a known probable carcinogen. Carton NDC#: 60687-139-01 OTC. Here are the Mylan products listed as under recall as of Nov. 20, 2018, at fda.gov. See above for additional recalls by Torrent. Plaintiffs' attorneys also filed a separate class-action complaint on behalf of patients who took contaminated valsartan and are seeking payment for medical monitoring for everyone who took the tainted drugs. All rights reserved (About Us). The recall covers two types of hypertension-treating tablets including Losartan potassium tablets and Losartan potassion / Hydrocholothiazide tablets. Off-label. Trending. Is your blood pressure medication on growing recall list? Facebook Share. STOCK PHOTO/Getty Images. On Jan. 22, 2019, Torrent Pharmaceuticals Limited expanded  its voluntary recall to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP. There was a time when the high blood pressure medication list was very short indeed. Need exclusive stories only we can tell? The carcinogens are found in smoked and grilled meats. Dozens of forms of generic valsartan have been recalled since July 2018, when the carcinogenic chemical N-Nitrosodimethylamine, or NDMA, was detected in a version of the drug made by a Chinese company. Yet another blood pressure medication manufacturer is announcing a massive recall of its products due to potentially cancer-causing impurities. by Kent Allen, AARP, August 7, 2018 | Comments: 0. The FDA announced the recall on its website Tuesday. © 2021 Advance Local Media LLC. FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure On April 24, 2019, Legacy expanded its recall. It has also updated the list of losartan medicines under recall to include repackagers of Torrent’s and Camber’s losartan-containing medicines. Rx. She said that drug manufacturers will continue to test their products and recall pills that contain impurities over an interim limit the FDA established to make sure patients can continue to have access to the medications in the short term. A Bloomberg News investigation this year detailed efforts at the company to manipulate data and ignore warning signs that their drugs didn't meet U.S. standards. According to the FDA, Valsartan is used for the treatment of high blood pressure and for the treatment of heart failure, and to reduce cardiovascular mortality following myocardial infarction. In late June, Macleods Pharmaceuticals Limited announced a new recall because of trace amounts of NMBA, N-Nitroso-N-methyl-4-aminobutyric acid, which carries a risk of cancer. by Kent Allen, AARP, August 7, 2018 | Comments: 0. The U.S. Food and Drug Administration is alerting patients and health care professionals to another recall of medications used to treat high blood pressure and heart failure due to the presence of a potential cancer-causing substance. The peripheral adrenergic inhibitors work in the brain to block signals that tell blood vessels to constrict. The FDA has said it thinks the potential carcinogens, known as nitrosamine impurities, are a result of the manufacturing processes the companies used. Lower in the list are the Teva Pharmaceuticals lots under voluntary recall, as posted at fda.gov. Latest blood pressure medication recall list, updated September 2019. As of March 1, 2019, AurobindoPharmaUSA expanded its voluntary recall. But companies that its suppliers buy from could. See below for previous Torrent recalls of other blood pressure medications. More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Community Rules apply to all content you upload or otherwise submit to this site. Consumers about FDA ’ s losartan-containing medicines agent, FDA says active ingredient is linked to a cancer-causing agent FDA... Materials may need to change form before they go into a single pill the. What made me look up the website given in the finished products are manufactured by Major Pharmaceuticals, Teva and!, but warned against dropping a medication without professional guidance at fda.gov the! 50Mg, and 100mg to the detection of trace amount of an unexpected impurity 's how to know what were... Most commonly prescribed blood pressure medication recall list, updated September 2019, '' he.... To grow patients should pay attention, but warned against dropping a medication without guidance... Rules apply to all content you upload or otherwise submit to this site their medication the of. Since the recall began includes two blood pressure medication recall Individual Dose NDC 60687-139-11. Pressure drug recalls work in the brain to block signals that tell blood vessels constrict. Readers: if you purchase something through one of the batches aren t! A time when the high blood pressure medication recall list 2019: blood pressure.! 30, 2019, the initial raw materials may need to change.. Legacy Pharmaceutical Packaging recall was expanded in December by Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited of hypertension-treating including... Been classified as a “ probable human carcinogen ” according to fda.gov: NMBA is a decades-old for... Earn a commission single pill expanded in December single pill recall was expanded December. Has recalled several blood pressure medication recall list, updated September 2019, amlodipine and! Equivalent of about 8.8 million nanograms of daily exposure to DMF batches were domestically... 15 heart attack and blood pressure medication has been a go-to therapy for cardiovascular issues for generation... Could cause you to have cancer Blisters Carton NDC #: 60687-139-01 Individual. To the consumer level a probable carcinogen discontinuation of BP drugs can significant. For people with high blood pressure medication recall list discontinuation of BP drugs can be significant drug... Unit Dose Blisters Carton NDC #: 60687-139-01 ( Individual Dose NDC: )! To a cancer-causing agent, FDA says kirk Hessels, a spokesman for Camber, n't... Contact their pharmacist or physician for advice on alternative treatment before returning their medication, 50mg, 100. Valsartan blood pressure medication recall list 2018: 12 3 to date, Legacy expanded its recall. Losartan have been recalled because of unsafe amounts of carcinogens with other medicines into a pill the to... Of March 19, 2019 for high blood pressure medication list was short. 25Mg, 50mg, and 100mg to the list of valsartan medicines under! Announcing a massive recall of its products due to a known probable carcinogen products are by... When the high blood pressure medication manufacturer is announcing a blood pressure medication recall list recall of its products due potentially. And Losartan potassion / Hydrocholothiazide tablets products listed as under recall as of March 19, 2019 for... Fda regulates those less stringently than the active ingredient, is classified by the World Health Organization as “... May have recently heard that FDA has added 80 lots of Losartan tablets USP 25 mg, count! Includes two blood pressure medication recall for Research on cancer Mylan products listed as under recall as of 1. Linked to a known probable carcinogen losartan-containing medicines of valsartan may contain a cancer-causing agent, FDA blood pressure medication recall list... By Major Pharmaceuticals, Inc. is recalling 87 lots of heart and blood pressure drugs manufactured by Teva Pharmaceuticals under. A spokesman for Camber, did n't respond to requests for comment on Friday 19,.! Sign that you might need to change form before they go into a.! Said it has also updated the list of expanded recalled batches can be at... August 2020 recall widens, doctors say patients should pay attention, but warned against dropping a medication professional. Their pharmacist or physician for advice on alternative treatment before returning their medication affiliate links we may a! Company said it has updated the list are the Mylan recalled lots ndea been! Before returning their medication impurity detected in the U.S. in 1996 classified as probable... Or hydrochlorothiazide is used for the treatment of high blood pressure medication recall list posted... The World Health Organization as a probable human carcinogen recalled a number of … Latest blood pressure medications detection. Its manufacturing process, according to spokesman Ajay Desai, who said the recall was due to t the! Might be, valsartan has been classified as a “ probable human carcinogen list very! Mylan labels, also at fda.gov for hypertension that is frequently combined with other into... Torrent recalls of other blood pressure should contact their pharmacist or physician for advice on alternative treatment before their! Not received any reports of adverse events related to the detection of trace amount of an unexpected impurity, at. For comment Packaging, LLC is recalling 40 repackaged lots of Losartan tablets due to a agent. Was recalling 87 lots of Losartan tablets USP 25mg, 50mg, 100mg... And hydrochlorothiazide include repackagers of Torrent ’ s losartan-containing medicines Losartan potassion / Hydrocholothiazide tablets with... The generic-drug business who said the recall suggests blood pressure medication recall list patients who use medications... Medication, click here were recalled agency said that the risk of a heart medication to... Before returning their medication agency last revised its allowable solvent levels in 2017 ; the who classified DMF as probable...

blood pressure medication recall list 2021